Tag: Arcus

Industry, Pharma

Gilead pays up to retain rights to Arcus cancer drugs

November 18, 2021

Via: Biopharma Dive

The initial deal between Gilead and Arcus gave the larger drugmaker rights to an experimental drug called zimberelimab, which attacks cancers using the same mechanism as Keytruda, along with an option to license the four projects covered by Thursday’s announcement. […]